Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026)

Alector's (ALEC) quarterly Non-Current Deffered Revenue came in at $162.9 million in Q2 2026, down 3.56% year-over-year from $168.9 million in Q2 2025, and little changed quarter-over-quarter from $162.9 million in Q1 2026.

Analysis

Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Non-Current Deffered Revenue for 9 consecutive years, with $162.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 3.56% year-over-year to $162.9 million in Q2 2026; TTM through Jun 2026 was $162.9 million, a 3.56% decrease from a year earlier, with the FY2025 full-year figure at $164.5 million, down 4.43% from the prior year.
  • Non-Current Deffered Revenue was $162.9 million for Q2 2026 at Alector, roughly flat from $162.9 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $505.1 million in Q1 2022 and troughed at $162.9 million in Q1 2026.
  • A 5-year average of $257.3 million and a median of $202.1 million in 2024 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue soared 378.83% in 2022 and tumbled 52.54% in 2024, its largest moves.
  • Over 5 years, Non-Current Deffered Revenue stood at $443.4 million in 2022, then slumped by 52.44% to $210.8 million in 2023, then declined by 18.34% to $172.2 million in 2024, then declined by 4.43% to $164.5 million in 2025, then decreased by 1.02% to $162.9 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $162.9 million (Q2 2026), $162.9 million (Q1 2026), and $164.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 220.40 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 147.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Alector 274.68 Mn 101.88 Mn - 162.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 162.87 Mn
Mar 31, 2026 162.87 Mn
Dec 31, 2025 164.54 Mn
Sep 30, 2025 167.27 Mn
Jun 30, 2025 168.87 Mn
Mar 31, 2025 170.31 Mn
Dec 31, 2024 172.17 Mn
Sep 30, 2024 192.78 Mn
Jun 30, 2024 199.58 Mn
Mar 31, 2024 204.58 Mn
Dec 31, 2023 210.85 Mn
Sep 30, 2023 229.85 Mn
Jun 30, 2023 245.34 Mn
Mar 31, 2023 431.08 Mn
Dec 31, 2022 443.37 Mn
Sep 30, 2022 386.36 Mn
Jun 30, 2022 413.90 Mn
Mar 31, 2022 505.13 Mn
Dec 31, 2021 334.42 Mn
Sep 30, 2021 344.53 Mn